These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26983831)

  • 21. Exosome-like Nanovectors for Drug Delivery in Cancer.
    Arrighetti N; Corbo C; Evangelopoulos M; Pastò A; Zuco V; Tasciotti E
    Curr Med Chem; 2019; 26(33):6132-6148. PubMed ID: 30182846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in exosome therapies in ophthalmology-From bench to clinical trial.
    Sanghani A; Andriesei P; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
    Acta Ophthalmol; 2022 May; 100(3):243-252. PubMed ID: 34114746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomes: Promising Delivery Tools for Overcoming Blood-Brain Barrier and Glioblastoma Therapy.
    Khatami SH; Karami N; Taheri-Anganeh M; Taghvimi S; Tondro G; Khorsand M; Soltani Fard E; Sedighimehr N; Kazemi M; Rahimi Jaberi K; Moradi M; Nafisi Fard P; Darvishi MH; Movahedpour A
    Mol Neurobiol; 2023 Aug; 60(8):4659-4678. PubMed ID: 37138197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy.
    Wang Y; Huo Y; Zhao C; Liu H; Shao Y; Zhu C; An L; Chen X; Chen Z
    J Control Release; 2024 Apr; 368():170-183. PubMed ID: 38382811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-BCMA-engineered exosomes for bortezomib-targeted delivery in multiple myeloma.
    Yuan S; Li Q; He C; Bing M; Zhang X; Xu H; Wang Z; Zhao M; Zhang Y; Chai Y; Li B; Zhuang W
    Blood Adv; 2024 Sep; 8(18):4886-4899. PubMed ID: 38875465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomes containing miRNAs targeting HER2 synthesis and engineered to adhere to HER2 on tumor cells surface exhibit enhanced antitumor activity.
    Wang L; Zhou X; Zou W; Wu Y; Zhao J; Chen X; Zhou GG
    J Nanobiotechnology; 2020 Oct; 18(1):153. PubMed ID: 33109196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain.
    Yuan D; Zhao Y; Banks WA; Bullock KM; Haney M; Batrakova E; Kabanov AV
    Biomaterials; 2017 Oct; 142():1-12. PubMed ID: 28715655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered Exosomes: A Promising Drug Delivery Strategy for Brain Diseases.
    Jiang Y; Wang F; Wang K; Zhong Y; Wei X; Wang Q; Zhang H
    Curr Med Chem; 2022; 29(17):3111-3124. PubMed ID: 34477508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosome-based immunotherapy: a promising approach for cancer treatment.
    Xu Z; Zeng S; Gong Z; Yan Y
    Mol Cancer; 2020 Nov; 19(1):160. PubMed ID: 33183286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosome-mediated delivery platform of biomacromolecules into the brain: Cetuximab in combination with doxorubicin for glioblastoma therapy.
    Chu L; Sun Y; Zhao Y; Wang A; Sun Y; Duan X; Li N; Xia H; Liu W; Sun K
    Int J Pharm; 2024 Jul; 660():124262. PubMed ID: 38815637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and Therapeutic Applications of Exosome Nanovesicles in Lung Cancer: State-of-The-Art.
    Mohammadi R; Hosseini SA; Noruzi S; Ebrahimzadeh A; Sahebkar A
    Anticancer Agents Med Chem; 2022; 22(1):83-100. PubMed ID: 33645488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unlocking the potential of exosomes in cancer research: A paradigm shift in diagnosis, treatment, and prevention.
    Khoushab S; Aghmiuni MH; Esfandiari N; Sarvandani MRR; Rashidi M; Taheriazam A; Entezari M; Hashemi M
    Pathol Res Pract; 2024 Mar; 255():155214. PubMed ID: 38430814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomes derived from microRNA-584 transfected mesenchymal stem cells: novel alternative therapeutic vehicles for cancer therapy.
    Kim R; Lee S; Lee J; Kim M; Kim WJ; Lee HW; Lee MY; Kim J; Chang W
    BMB Rep; 2018 Aug; 51(8):406-411. PubMed ID: 29966581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomes in sarcoma: Prospects for clinical applications.
    Ye H; Tan L; Tu C; Min L
    Crit Rev Oncol Hematol; 2023 Jan; 181():103895. PubMed ID: 36481305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomes in Renal Cell Cancer: Diagnostic and Therapeutic Nanovehicles.
    Boussios S; Ovsepian SV
    Technol Cancer Res Treat; 2024; 23():15330338241275403. PubMed ID: 39149973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Exosomes in the Progression, Diagnosis, and Treatment of Gliomas.
    Shi J; Zhang Y; Yao B; Sun P; Hao Y; Piao H; Zhao X
    Med Sci Monit; 2020 Nov; 26():e924023. PubMed ID: 33245712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomes as Novel Diagnostic Biomarkers and Therapeutic Tools in Gliomas.
    Skouras P; Gargalionis AN; Piperi C
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomes and cancer: From oncogenic roles to therapeutic applications.
    Mohammadi S; Yousefi F; Shabaninejad Z; Movahedpour A; Mahjoubin Tehran M; Shafiee A; Moradizarmehri S; Hajighadimi S; Savardashtaki A; Mirzaei H
    IUBMB Life; 2020 Apr; 72(4):724-748. PubMed ID: 31618516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2.
    Yu L; Gui S; Liu Y; Qiu X; Zhang G; Zhang X; Pan J; Fan J; Qi S; Qiu B
    Aging (Albany NY); 2019 Aug; 11(15):5300-5318. PubMed ID: 31386624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomes as drug delivery systems: A brief overview and progress update.
    Patil SM; Sawant SS; Kunda NK
    Eur J Pharm Biopharm; 2020 Sep; 154():259-269. PubMed ID: 32717385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.